Food noise: Genotypic or phenotypic gluttony?
Dr Sourav Roy. 29 April, 2026

I, as a neuroscientist and connoisseur of fine cuisine, often find myself reflecting on how profoundly our modern environment shapes the way we think about food. The recent rise of the term “food noise” in GLP‑1 marketing has been especially interesting to watch, because it captures a real cognitive experience—intrusive, persistent food‑related thoughts—yet it is also being shaped by commercial narratives that may oversimplify what is, in reality, a deeply layered neurobiological and environmental phenomenon. Scientific literature describes food noise as a form of intrusive cognition driven by heightened cue‑reactivity and reward salience rather than a simple excess of appetite (1). Neuroimaging studies show that GLP‑1 receptor agonists reduce activation in regions such as the insula, amygdala, and orbitofrontal cortex when individuals view food cues, suggesting that these medications dampen the neural circuits that normally amplify the cognitive pull of food stimuli (2, 3). This is compelling evidence, but it does not fully explain why some people experience food noise intensely while others do not.

This is where my conceptual distinction between Genotypic Gluttony™ and Phenotypic Gluttony™ becomes useful. Genotypic Gluttony™ refers to inherited predispositions—genetic variants that influence appetite regulation, reward sensitivity, or metabolic efficiency. There is evidence that genetic variation affects individual responsiveness to GLP‑1 agonists, with certain receptor polymorphisms predicting stronger or weaker therapeutic effects (4). Yet these genetic factors alone cannot account for the intrusive, repetitive thoughts that people describe as food noise. Instead, the phenomenon aligns more closely with Phenotypic Gluttony™, the behavioural expression of overeating or food‑related rumination shaped by environmental cues, cultural norms, stress, and learned associations. Studies show that individuals with obesity often exhibit heightened striatal responses to high‑calorie food cues and reduced endogenous GLP‑1 secretion after meals, linking environmental dietary patterns to neural sensitivity (5). This suggests that food noise is not simply “in the genes” but emerges from the interaction between neurobiology and an environment saturated with hyper‑palatable foods and constant cues.

From an evolutionary perspective, this makes sense. For most of human history, obtaining food required effort, planning, and sometimes risk. The absence of such struggle in modern life creates a mismatch between our evolved reward circuits and the conditions we now inhabit. When food is abundant, inexpensive, and engineered to be maximally rewarding, the brain’s motivational systems can become overstimulated. Research on cue‑induced eating shows that external triggers—images, smells, memories, even stress—can activate reward pathways independently of hunger, producing intrusive thoughts that resemble what people now call food noise (6). The CIRO model of cue reactivity integrates these findings by showing how cues, internal states, reward learning, and opportunity interact to produce persistent food‑related cognition (7). This framework reinforces the idea that food noise is a learned, environmentally amplified cognitive pattern rather than a fixed biological trait.

GLP‑1 medications undeniably reduce this intrusive salience. Studies demonstrate that they modulate dopaminergic signalling, reduce anticipatory reward responses, and alter functional connectivity in networks involved in craving and impulse control (2, 3, 8). Yet these effects do not distinguish between genotypic predisposition and phenotypic expression; they simply attenuate the downstream cognitive and behavioural manifestations. Marketing narratives, however, often present food noise as a universal biological problem that GLP‑1 drugs uniquely solve. This framing risks obscuring the fact that only a subset of individuals; those whose phenotypic patterns interact with modern abundance to produce intrusive rumination are likely to experience dramatic relief. It also risks pathologising normal variation in appetite and cognition, especially when the scientific evidence remains early and evolving.

As someone who studied the brain but also appreciates the sensory pleasures of food, I find it important to approach this topic with nuance.

GLP‑1 medications can offer meaningful relief. But the phenomenon is not monolithic, and it is not solely biological. It reflects a complex interplay between neural circuitry, environmental cues, cultural expectations, and personal history. Recognising this complexity invites a more thoughtful conversation about why food occupies so much cognitive space for some individuals and not others. It also encourages us to consider how modern abundance shapes our mental landscapes in ways that our ancestors never encountered.

In this light, distinguishing between Genotypic Gluttony™ and Phenotypic Gluttony™is not about labelling people but about understanding the layered origins of their experiences. Food noise may be best understood as a manifestation of Phenotypic Gluttony™, a behavioural adaptation to an environment that no longer requires struggle or scarcity. GLP‑1 medications may quiet this phenotype by modulating neural circuits, but they do not resolve the underlying environmental mismatch. Acknowledging this opens the door to richer, more inclusive discussions about appetite, cognition, and the modern food environment—conversations that welcome differing perspectives rather than closing them off.

References

(1) Cook et al., Cureus, 2026.

(2) van Bloemendaal et al., Diabetes, 2014.

(3) Farr et al., Cell Metabolism, 2016.

(4) Choi et al., Nature Medicine, 2025.

(5) Sidharthan et al., Nutrients, 2023.

(6) Boswell & Kober, Psychological Bulletin, 2016.

(7) Hayashi et al., Nutrients, 2023.

(8) Ten Kulve et al., Diabetes Care, 2016.

(9) Berthoud, Physiology & Behavior, 2011.

(10) Lowe & Butryn, Appetite, 2007.

Also available on
https://www.linkedin.com/pulse/food-noise-genotypic-phenotypic-gluttony-dr-sourav-roy-opsde
https://drroys.substack.com/